Mark Rubinstein to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Mark Rubinstein has written about Xenograft Model Antitumor Assays.
Connection Strength
0.071
-
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Ra Complexes Enhances Tumor Control. Cancer Immunol Res. 2019 08; 7(8):1371-1380.
Score: 0.039
-
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses. J Biol Chem. 2016 Nov 11; 291(46):23869-23881.
Score: 0.032